TCT 2018 | PREPARE-CALC: Rotational Atherectomy vs. Cutting Balloon in Calcified Lesions

Compared against conventional predilation with balloon, rotational atherectomy is associated with higher procedural success rate in severely classified lesions. Balloons capable of modifying plaque such as the Flextome Cutting Balloon or the AngioSculpt Scoring Balloon -among others- could reach similar results to that of rotational atherectomy, though this has not been tested so far.

TCT 2018 | PREPARE-CALC: aterectomía rotacional vs Cutting Balloon en lesiones calcificadas200 patients with documented ischemia and severely calcified native coronary lesions were randomized to rotational atherectomy vs. cutting balloon in preparation to stenting, followed by sirolimus bioresorbable polymer-based DES implantation (Orsiro).

 

The study, presented at TCT 2018 and simultaneously publish in Circulation, had two primary end points: on the one hand, strategy success (successful stenting with <20% residual stenosis and TIMI 3 flow) and, on the other hand, late lumen loss at 9 months.


Read also: TCT 2018 | NEOPRO: A Registry for Acurate neo and Evolut PRO.


Procedural success was superior for rotational atherectomy (81% vs 98%; p=0.001) though with mean 5 more minutes of fluoroscopy time. Late lumen loss resulted non-inferior for both strategies. Need for revascularization and definite stent thrombosis rates were similar with both strategies.

 

Conclusion

Preparing severely calcified lesions with rotational atherectomy has higher procedural success than with cutting balloons. In time, operators will acquire the experience to know when to use rotational atherectomy and will learn to cross over when the simpler strategy won’t work.  

 

Original title: A Randomized Trial of High-Speed Rotational Atherectomy Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.

Presenter: Gert Richardt.

 

PREPARE-CALC-presentación

PREPARE-CALC-artículo-original


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....